AstraZeneca PLC ADR

AZN NASDAQ
Overview Stats Financials News

Quarterly Financials

Values in thousands 2024-03-31 2023-12-31 2023-09-30 2023-06-30
Revenue $12,679,000 $12,024,000 $11,492,000 $11,416,000
Gross Profit 9,536,000 9,716,000 9,397,000 9,456,000
EBITDA 4,500,000 2,909,000 3,326,000 2,519,000
EBIT 3,245,000 2,035,000 2,044,000 1,243,000
Net Income 2,179,000 960,000 1,374,000 1,818,000
Net Change In Cash 12,679,000 12,024,000 11,492,000 11,416,000
Free Cash Flow 974,000 1,434,000 2,235,000 1,235,000
Cash 7,841,000 5,840,000 4,871,000 5,664,000
Basic Shares 3,120,000 3,122,000 3,120,000 3,120,000

Annual Financials

Values in thousands 2023-12-31 2022-12-31 2021-12-31 2020-12-31
Revenue $45,811,000 $44,351,000 $37,417,000 $26,617,000
Gross Profit 37,543,000 31,960,000 24,980,000 21,318,000
EBITDA 13,911,000 9,327,000 7,565,000 8,371,000
EBIT 8,977,000 3,757,000 1,056,000 5,162,000
Net Income 5,955,000 3,288,000 112,000 3,196,000
Net Change In Cash 45,811,000 44,351,000 37,417,000 26,617,000
Free Cash Flow 6,567,000 7,237,000 3,763,000 2,193,000
Cash 5,840,000 6,166,000 6,329,000 7,832,000
Basic Shares 3,124,000 3,120,000 2,854,000 2,626,000

Earnings Calls

Quarter EPS
2024-03-31 $1.03
2023-12-31 $0.73
2023-09-30 $0.87
2023-06-30 $1.08